Alphatec Holdings (ATEC) Cash from Financing Activities (2010 - 2026)
Alphatec Holdings (ATEC) posted Cash from Financing Activities of -$1.8 million for Q1 2026, down 961.17% sequentially from $206000.0 in Q4 2025, and down 105.77% YoY from $30.8 million in Q1 2025.
Alphatec Holdings (ATEC) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Alphatec Holdings has reported Cash from Financing Activities for 17 years, with the latest figure at -$1.8 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 105.77% year-over-year to -$1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 million (down 102.75% YoY) and the FY2025 annual result came in at $30.0 million, down 46.59% from the prior year.
- Cash from Financing Activities slipped to -$1.8 million in Q1 2026 per ATEC's latest filing, from $206000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $151.6 million in Q4 2023 and troughed at -$4.4 million in Q1 2024.
- A 5-year average of $27.8 million and a median of $3.2 million in 2024 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities surged 14862.59% in 2023, then tumbled 119.61% in 2025.
- Over 5 years, Cash from Financing Activities stood at $1.0 million in 2022, then soared by 14862.59% to $151.6 million in 2023, then sank by 66.59% to $50.6 million in 2024, then tumbled by 99.59% to $206000.0 in 2025, then slumped by 961.17% to -$1.8 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$1.8 million, $206000.0, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Alphatec Holdings | 1.48 Bn | 1.36 Bn | 154.10 Mn | -19.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.53 Mn |
| Jun 30, 2026 | -19.53 Mn |
| Mar 31, 2026 | -1.77 Mn |
| Mar 31, 2026 | -1.77 Mn |
| Dec 31, 2025 | 206,000.00 |
| Dec 31, 2025 | 206,000.00 |
| Sep 30, 2025 | -1.31 Mn |
| Sep 30, 2025 | -1.31 Mn |
| Jun 30, 2025 | 366,000.00 |
| Jun 30, 2025 | 366,000.00 |
| Mar 31, 2025 | 30.76 Mn |
| Mar 31, 2025 | 30.76 Mn |
| Dec 31, 2024 | 50.64 Mn |
| Dec 31, 2024 | 50.64 Mn |
| Sep 30, 2024 | 6.69 Mn |
| Sep 30, 2024 | 6.69 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Mar 31, 2024 | -4.37 Mn |
| Mar 31, 2024 | -4.37 Mn |